- Pfizer Inc (PFE) Q1 2019 Earnings Call Transcript Motley Fool
- Pfizer (PFE) Beats on Q1 Earnings & Sales, Raises EPS View Yahoo Finance
- Pfizer Earnings Top Estimates as New CEO Bourla Takes Reins Bloomberg
- Pfizer Inc. (PFE) CEO Albert Bourla on Q1 2019 Results - Earnings Call Transcript Seeking Alpha
- Vaccine and blood thinner help drive Pfizer to quarterly earnings beat Reuters
- View full coverage on Google News
PFIZER INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Pfizer Inc. - PFE Yahoo Finance
- What You Must Know About Pfizer Inc.?s (NYSE:PFE) Financial Strength Simply Wall St
- Cheviot Value Management Trimmed Pfizer (PFE) Stake by $368,596 as Stock Declined; As At&T (T) Stock Value Declined, Sns Financial Group Cut Stake by $1.27 Million The EN Herald
- Telos Capital Management Inc. Increases Holdings in Pfizer Inc. (PFE) Mayfield Recorder
- Pfizer Inc. (PFE) Position Trimmed by Xact Kapitalforvaltning AB Tech Know Bits
- Pfizer Inc. (PFE) Position Trimmed by Jarislowsky Fraser Ltd Rockland Register
- View full coverage on Google News
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (?KSF?), announces that KSF has commenced ...
Pfizer: Added Value For A Defensive Pharma Portfolio Seeking Alpha
Of the 6 largest pharmaceutical companies by market cap, Pfizer is the most balanced and with the shallowest patent cliff. Its best selling drugs are immune to.
Pfizer: A 3.5% Yield, But Lyrica's Patent Loss Keeps Me From Buying Seeking Alpha
Pfizer Inc. is a global biopharma giant with a 3.5% dividend yield and a broad portfolio of therapies and consumer healthcare products. Pfizer has invested in R.
Pfizer Posts Positive Phase 3 Study In Eczema, Catalysts Remain In Second Half Of 2019 Seeking Alpha
Pfizer announced that it had achieved positive top-line results from its phase 3 study using abrocitinb to treat patients with atopic dermatitis (eczema). Top-l.
Where Will Pfizer Be in 5 Years? Motley Fool
The last five years were good for Pfizer shareholders. Here's how the next five could be different.
Pfizer Nabs Regulatory Approval For Tafamidis, An FDA First Is Achieved Seeking Alpha
Pfizer obtained FDA approval for drugs Vyndaqel and Vyndamax to treat patients with transthyretin amyloid cardiomyopathy. Vyndaqel and Vyndamax are the ...
Pfizer (PFE) Phase 3 Trial of LYRICA in PGTC Seizures Did Not Meet its Primary Endpoint StreetInsider.com
Pfizer Inc. (NYSE: PFE) announced today that a Phase 3 study to assess the use of LYRICA® (pregabalin) as adjunctive therapy for epilepsy patients 5 to 65 ...
Better Buy: AbbVie vs. Pfizer Yahoo Finance
AbbVie and Pfizer are both undergoing a radical makeover. Which company should investors trust to come out even stronger?
Better Buy: Eli Lilly vs. Pfizer The Motley Fool
If you're looking to add a big pharma stock to your portfolio, Eli Lilly (NYSE:LLY) and Pfizer (NYSE:PFE) are naturally two top candidates. Both big drugmakers ...
Pfizer Acquires Therachon, Looks To Add To Rare Disease Pipeline Seeking Alpha
Pfizer acquires private biotech Therachon to gain a clinical product, known as TA-46, to treat patients with Achondroplasia. Pfizer paid an upfront payment of $
Pfizer Beats In Q1 But Lyrica Headwinds Will Likely Weigh On Near Term Growth Forbes
Pfizer (NYSE:PFE) recently reported its Q1 2019 results, which were above our estimates. This note details the company's Q1 performance, and Trefis' forecast ...
Can Pfizer Leap Over the Competition With This Potential Blockbuster? Yahoo Finance
The Food and Drug Administration (FDA) often sends new drug applications back to pharmaceutical companies with requests for more evidence. Recently ...
Pfizer?s Pipeline Makes Progress as Sales Grow The Wall Street Journal
Pfizer's new portfolio of prescription drugs lifted sales during the first quarter as the company said it continues to make progress on growing through its internal ...
Google sister-company Verily is teaming with big pharma on clinical trials CNBC
Verily, Alphabet's health and life sciences division, is moving into the clinical trials market. It just announced strategic alliances with Novartis, Sanofi, Otsuka and ...
Pfizer Stock: Is It A Buy Right Now? Here's What Earnings, PFE Chart Show Investor's Business Daily
Pfizer stock has fallen harder than other drug makers this year. News has been upbeat with a drug approval and earnings beat. Is Pfizer a buy right now?
Pfizer Denies Encouraging Drug Abuse By Packaging Fentanyl With Cooking Spoon, Lighter The Onion
NEW YORK?In an effort to address the growing controversy surrounding widespread non-medical use of their products, pharmaceutical giant Pfizer released a ...
FDA OKs expanded use of Pfizer's anticoagulant Fragmin Seeking Alpha
The FDA has approved Pfizer's (PFE +1.2%) Fragmin (dalteparin sodium) injection to reduce the recurrence of symptomatic venous thromboembolism (VTE) in ...
Teva, Pfizer, Sandoz among 20 companies accused of illegally hiking generic drug prices NorthJersey.com
Federal authorities say 20 companies, including Teva, Sandoz and Pfizer, illegally conspired to hike generic drug prices.
Insurers Brace For Pfizer's $225K Heart Drug And Whether To Pay For It Forbes
It's unclear whether health insurers and PBMs will cover Pfizer's $225000 a year drug tafamidis to treat a rare heart disease.
Pfizer gets U.S. approval for $225,000 a year heart drug Reuters
NEW YORK (Reuters) - The U.S. Food and Drug Administration on Monday approved Pfizer Inc's oral drug, tafamidis, to treat a rare and fatal heart disease ...
5 Reasons Why Pfizer Is a Great Stock to Buy and Hold for the Long Term The Motley Fool
A few bumps in the road might be on the way, but this big pharma stock should have pretty smooth sailing over the next decade.
Pfizer Lifts 2019 Earnings Forecast as Biopharma Sales Drive Q1 Profit Beat TheStreet.com
Pfizer posted stronger-than-expected first quarter earnings Tuesday, and boosted the mid-point of its full-year profit forecast thanks to anticipated gains in ...
Pfizer Gains After Being Named 'Top Pick' by Credit Suisse TheStreet.com
Shares of Pfizer (PFE - Get Report) posted gains on Thursday after the drugmaker was named a "top pick" at Credit Suisse following a meeting the analysts had ...
Better Buy: Pfizer vs. AbbVie The Motley Fool
Which big pharma stock is more likely to be the bigger winner over the long run?
Eli Lilly, Merck, and Pfizer Earnings Are Coming. Here?s What to Watch. Barron's
The three big pharmaceutical companies ? Eli Lilly, Merck, and Pfizer ? are due to release their results on Tuesday. Although health care had a fairly good ...
Pfizer And Others Join Working Group To Use Blockchain Protocol For Supply Chain Management Forbes
Pfizer Inc., McKesson Corporation, AmerisourceBergen Corporation, and Premier Inc. have all joined the MediLedger Project Contracting and Chargebacks ...
Sarepta: Buy The Pfizer Selloff Seeking Alpha
Pfizer's upcoming data reveal created a perfect sell the news event for Sarepta. The road to DMD drug greatness is strewn with failures as Pfizer has a lot to p.
Pfizer to buy Therachon for $340M, taking on BioMarin, Ascendis BioPharma Dive
Pfizer will pay $340 million upfront to acquire a private biotech, taking over development of an experimental dwarfism therapy that will pit the giant drugmaker ...
Credit Suisse Absolutely Is Right to Double Down on Pfizer Stock Investorplace.com
Buy Pfizer stock on this current round of weakness. As Credit Suisse knows, the underpinnings are bullish for 2020 and beyond.
Top vaccine makers Merck and Pfizer target China and older adults next CNBC
Four giant companies now dominate global vaccine sales. With newer and more expensive vaccines becoming available, the market value of vaccines could ...
Pfizer touts late-stage win for JAK drug that could duel with Dupixent BioPharma Dive
Pfizer said Wednesday its experimental JAK1 inhibitor succeeded in a pivotal eczema study, although safety questions remain largely unanswered in a sparse ...
Here are the biggest analyst calls of the day: Macy's, Pfizer, Owens Corning & more Yahoo Finance
Here are the biggest calls on Wall Street on Thursday: Goldman Sachs upgraded Macy's to 'neutral' from 'sell'. Goldman said the underperformance of the stock ...
The Zacks Analyst Blog Highlights: Teva, Mylan, Novartis and Pfizer Yahoo Finance
For Immediate Release. Chicago, IL ?May 15, 2019 ? Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research ...
Pfizer profit jumps 9% on higher sales, lower costs Champaign/Urbana News-Gazette
Higher prescription drugs sales and restrained spending together gave drugmaker Pfizer a 9% jump in first quarter profit as it easily topped analysts' profit ...
Pharma Stock Roundup: FDA Okays Line Extensions of LLY, PFE, ABBV Cancer Drugs Zacks.com
FDA grants approval for line extensions of Lilly (LLY), Pfizer (PFE) and Roche (RHHBY)/AbbVie's (ABBV) cancer drugs.
Pfizer, Inc. (PFE) Ex-Dividend Date Scheduled for May 09, 2019 Nasdaq
Pfizer, Inc. ( PFE ) will begin trading ex-dividend on May 09, 2019. A cash dividend payment of $0.36 per share is scheduled to be paid on June 07,.
Pfizer Earnings, Merck Earnings Top; Eli Lilly Falls On Revenue Investor's Business Daily
Pfizer earnings and Merck earnings beat, with the Dow drug giants giving decent outlooks. Pfizer stock, Merck stock rose. Eli Lilly stock fell on revenue.
Merck, Pfizer Stock Rise, Lilly Slips as Big Pharma Earnings Roll In Barron's
Both Merck stock and Pfizer stock are were on the rise Tuesday morning after reporting first-quarter earnings, while Eli Lilly stock slipped into the red following ...
Top Stock Reports for Pfizer, Intel & HCA Healthcare Yahoo Finance
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, ...
Pfizer jumps into the heated PhIII race for new-wave JAK inhibitors ? but safety frets loom large Endpoints News
Pfizer has racked up a positive slate of Phase III data for its anti-?inflammatory JAK1 inhibitor abrocitinib (PF-?04965842), which the pharma giant is hoping to ...
Get Back into Growth Stocks Like Pfizer Inc. (PFE), Nokia Corporation (NOK) Financial Mercury
Looking at top Wall Street opinions, Pfizer Inc. (NYSE: PFE) has recently made its way into the research list of Citigroup ? signaling that their analyst's rating ...
CCI approves GSK, Pfizer consumer healthcare JV formation Livemint
CCI in a tweet confirmed about the approval of the JV.The proposed combination involves acquisition of Pfizer's consumer healthcare business by GSK.
Pfizer prospects for tafamidis market BioPharma Dive
Pfizer expects the Food and Drug Administration to decide in July on approval of tafamidis in the rare disease transthyretin amyloid cardiomyopathy. Assuming ...
Pfizer unveils new manufacturing facility | News Andover Townsman
A ribbon-cutting ceremony held last Thursday morning celebrated Pfizer's new 175000-square-foot clinical manufacturing facility at the company's campus on ...
Risk-Based Monitoring: Pfizer and BMS Seek Clarity on FDA Draft Guidance Regulatory Focus
Pfizer and Bristol-Myers Squibb (BMS) recently raised questions with and sought further clarity from the US Food and Drug Administration (FDA) on a draft ...
Stocks making the biggest moves premarket: Walmart, Pfizer, PG&E, Sony, Tesla & more CNBC
Check out the companies making headlines before the bell: Walmart ? The retail giant reported adjusted quarterly profit of $1.13 per share, 11 cents a share ...
Pfizer's Eczema Candidate Meets All Goals in Phase III Study Yahoo Finance
Pfizer's (PFE) investigational eczema treatment abrocitinib succeeds in pivotal late-stage study.
Hope Is All Investors Have To Hold Onto: United Parcel Service, Inc. (UPS), Pfizer Inc. (PFE) Post Analyst
The opening price for United Parcel *Service*, Inc. (NYSE:UPS) was $98.72 and the volume amounted to 3086922 shares which compares with the average ...
Pfizer opens $200m clinical manufacturing plant in MA BioProcess Insider
The multiproduct facility will support early-phase manufacturing for its biologics pipeline, Pfizer says. Last week, pharma giant Pfizer cut the ribbon on the latest ...
Brainstorm Health: Royal Baby, All of Us, Pfizer Heart Drug Approval Fortune
Happy Monday, readers. I hope you've had a wonderful weekend. Alright, I'll come clean up top? This sort of is about the royal baby. But only as a point of ...
Healthcare Transformer 2019: Lidia Fonseca, Pfizer - Top 40 Transformers - MM&M Medical Marketing and Media
You might say Lidia Fonseca has been solving problems since she was a little girl. Born in Mexico, Fonseca moved to the U.S. when she was 10. ?I learned to ...
Which Stock Worth Buying? Pfizer, Inc. (NYSE:PFE), Arcos Dorados Holdings Inc. (NYSE:ARCO) The Newburgh Press
Pfizer, Inc. (NYSE:PFE) Pfizer, Inc. (NYSE:PFE), ended its previous trading session at $41.92 showing a loss of -0.0700000000000003 or -0.17 percent with.
Pfizer stock up 1.7% after earnings and revenue beat MarketWatch
Shares of Pfizer rose 1.7% in premarket trade Tuesday after the company reported first-quarter earnings and revenue that beat expectations, while raising its...
44 AGs File Antitrust Lawsuit Against Pfizer, Teva for Allegedly Fixing Prices of Generic Drugs | Connecticut Law Tribune Law.com
Connecticut is leading a 44-state coalition alleging price-fixing by 20 makers of generic drugs. Their lawsuit seeks payments of billions of dollars to these states.
Redmond Asset Management Lowered Its Tractor Supply Co (TSCO) Holding by $2.05 Million as Shares Declined; As Pfizer (PFE) Stock Declined, Meiji Yasuda Life Insurance Company Has Cut by $458,681 Its Holding The EN Herald
Redmond Asset Management Llc decreased its stake in Tractor Supply Co (TSCO) by 42.69% based on its latest 2018Q4 regulatory filing with the SEC.
Updated: Pfizer Calls for Compromise on Retroactively Using Suffixes in Biologic Names Regulatory Focus
In response to the US Food and Drug Administration's (FDA) proposal to not go back and rename certain biologics with nonsense suffixes, as it once said it ...
Markston International Holding in Pfizer (PFE) Decreased by $516,000; Cisco Sys (CSCO) Holder Signature Estate & Investment Advisors Has Trimmed Position as Stock Value Rose The EN Herald
Markston International Llc decreased its stake in Pfizer Inc. (PFE) by 6.61% based on its latest 2018Q4 regulatory filing with the SEC. Markston International ...
Exact Sciences starts to see payoff from Pfizer marketing tie-up FierceBiotech
Exact Sciences has begun to reap both the benefits and drawbacks since it kicked off a sales and marketing partnership with Pfizer late last year to help promote ...
Pfizer Inc. Issues A Voluntary Nationwide Consumer Level Recall of One Lot of ThermaCare® Back Pain Therapy HeatWraps, up to 16HR pain relief, Due To Out of Specification Results for High Cell Temperature FDA.gov
When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company's announcement as a public *service*. FDA does not endorse ...
What Are Analysts Recommending for PFE after Q1 Results? Market Realist
On April 30, Pfizer (PFE) reported first-quarter results. The company reported revenues of $13.12 billion in the first quarter, a YoY rise of 2% on a reported basis ...
Pharma Stock Roundup: MRK, LLY, PFE Report Q1 Earnings, SNY, ABBV Drugs Get EU Nod Zacks.com
Merck (MRK), Pfizer (PFE), Lilly (LLY) announce Q1 results. European Commission grants approval to AbbVie's (ABBV) Skyrizi and Sanofi's (SNY) Zynquista.
Is A Downturn Overdue? Pfizer Inc. (PFE), Nordstrom, Inc. (JWN)? Financial Mercury
The shares of Pfizer Inc. (NYSE:PFE) has been pegged with a rating of Neutral by Citigroup in its latest research note that was published on February 20th, 2019 ...
CCI approves GSK, Pfizer joint venture in consumer healthcare Economic Times
GSK had in December last year announced that it had reached an agreement with Pfizer to combine the two companies consumer healthcare businesses. ??
GSK-Pfizer deal gets approval from Australia's anti-trust watchdog Reuters
(Reuters) - GlaxoSmithKline's deal to buy Pfizer's consumer healthcare business will not lesson competition in Australia, the country's anti-trust regulator said on ...
Apg Asset Management Nv Position in Pfizer (PFE) Has Lifted as Stock Value Declined; Intel Corp. (INTC) Holder Opus Investment Management Trimmed Its Holding by $575,000 as Share Price Rose The EN Herald
Opus Investment Management Inc decreased its stake in Intel Corp. (INTC) by 10.05% based on its latest 2018Q4 regulatory filing with the SEC.
Shocking Stock: Pfizer Inc. (NYSE:PFE) Alpha finews
On 05-24-2k19 (Friday), Shareholders tracking shares of Pfizer Inc. (PFE) belongs to Healthcare sector and Drug Manufacturers ? Major industry. PFE flaunted ...
Pfizer Receives Positive CHMP Opinion for TALZENNA® (talazoparib) for Patients with Inherited (Germline) BRCA-Mutated Locally Advanced or Metastatic Breast Cancer Yahoo Finance
Pfizer Inc. (PFE) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a ...
Stocks to Watch: Alphabet, McDonald?s, General Electric, Gardner Denver, Pfizer, Mastercard, Western Digital, MGM Resorts, ConocoPhillips The Wall Street Journal
Companies with shares expected to trade actively in Tuesday's session include Alphabet, Western Digital, MGM Resorts International and GE.
Tom Miller, Iowa's attorney general, joins multi-state lawsuit against Teva, Pfizer over inflated drug prices Des Moines Register
It's unclear whether the lawsuit would be affected by a bill that would limit the attorney general's power to join out-of-state cases.
Ciena Com New (CIEN) Stake Maintained by Essex Investment Management Co Llc; Oldfield Partners Llp Has Cut Pfizer (PFE) Stake by $2.60 Million; Market Valuation Declined The EN Herald
Essex Investment Management Co Llc increased its stake in Ciena Corp Com New (CIEN) by 626.14% based on its latest 2018Q4 regulatory filing with the SEC.
Pfizer Com (PFE) Shareholder Raab & Moskowitz Asset Management Cut Its Stake by $328,262 as Stock Declined; Bbva Compass Bancshares Decreased Its Baidu (BIDU) Position by $693,778 The EN Herald
Raab & Moskowitz Asset Management Llc decreased its stake in Pfizer Inc Com (PFE) by 5.44% based on its latest 2018Q4 regulatory filing with the SEC.
Pfizer Inc (PFE) Sees Rank Correlation Indicator Trend Towards Potential Reversal Hermann Herald
Pfizer Inc (PFE) shares are being closely watched as the Rank Correlation Indicator has shown an upward 3 bar near-term trend, indicating that a reversal.
?Global Doxorubicin Market 2019 ? Pfizer, Johnson & Johnson, Sun Pharmaceutical Industries, Meiji Seika Pharma ? Journallic Journallic
The Global Doxorubicin market report is a most important research for who looks for complete information on the Doxorubicin market. The report covers all ...
Veletri Market 2019 SWOT Analysis by Players: Pfizer (US), Sanofi SA (France), Bayer HealthCare Pharmaceuticals (Germany), Actelion Pharmaceuticals (Switzerland) Fox World Media
The global Veletri report to 2024 covers the market background and its growth prospects on the upcoming years additionally briefs about Veletri product life span ...
Grisanti Capital Management Holding in New Residential Invt (NRZ) Has Raised as Market Valuation Declined; Beacon Financial Group Decreased Its Position in Pfizer (PFE) as Market Value Declined The EN Herald
Grisanti Capital Management Llc increased its stake in New Residential Invt Corp (NRZ) by 1934.03% based on its latest 2018Q4 regulatory filing with the SEC.
Fagan Associates Has Cut Its Nvidia (NVDA) Stake by $1.19 Million as Market Value Declined; Verity Asset Management Holding in Pfizer (PFE) Boosted as Market Valuation Declined The EN Herald
Fagan Associates Inc decreased its stake in Nvidia Corp (NVDA) by 50.14% based on its latest 2018Q4 regulatory filing with the SEC. Fagan Associates Inc sold ...
10 things to know ahead of Pfizer's earnings report New York Business Journal
The report comes just days after shareholders met and celebrated the success that the New York-based pharmaceutical giant.
Health Care Sector Update for 05/24/2019: SURF, BMY, CELG, AXSM, JNJ, PFE, ABT, MRK, AMGN Nasdaq
Top Health Care Stocks: JNJ: -0.51% PFE: -0.48% ABT: Flat MRK: +0.21% AMGN: Flat Leading health care stocks were mixed pre-market Friday. Early.
Antibody Drug Conjugates Market Production Growth Rate 2019-2025 Pfizer, Seattle Genetics, Genentech. Worldwide Market
A market study on the ?Global Antibody Drug Conjugates Market Research Report 2019-2025?? By QYMarketStudy. It analyses the important factors of the ...
?Global Cough Remedies Market 2019 ? Pfizer, Johnson & Johnson, GlaxoSmithKline, Novartis ? Journallic Journallic
The Global Cough Remedies market report is a most important research for who looks for complete information on the Cough Remedies market. The report ...
Global Pharma and Cetirizine OTC Market Analysis by 2025: UCB Pharma, Pfizer, J & J, Mylan, Teva, HUAPONT Pharm Industry Herald
The global ?Pharma and Cetirizine OTC market? research report is crafted with the concise assessment and extensive understanding of the realistic data of the ...
Pfizer' Talzenna leads latest CHMP highlights PharmaTimes
Thirteen medicines were recommended for approval at the committee's April 2019 meeting. - News - PharmaTimes.
Nci Building Sys (NCS) Holder Chicago Equity Partners Lowered Its Stake as Market Valuation Declined; Naples Global Advisors Has Raised Holding in Pfizer (PFE) by $373,506 as Stock Value Declined The EN Herald
Chicago Equity Partners Llc decreased its stake in Nci Building Sys Inc (NCS) by 38.37% based on its latest 2018Q4 regulatory filing with the SEC. Chicago ...
After Hours Most Active for May 10, 2019 : COTY, PFE, UBER, HLF, MRK, DOW Nasdaq
The NASDAQ 100 After Hours Indicator is up 1.79 to 7588.32. The total After hours volume is currently 54525339 shares traded. The following.
The Zacks Analyst Blog Highlights: Pfizer, Intel, HCA Healthcare, Xilinx and Cummins Yahoo Finance
For Immediate Release. Chicago, IL ? May 6, 2019 ? Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research ...
A straightforward reality behind these stocks: Pfizer Inc. (PFE), Halliburton Company (HAL) FinBulletin
Over the last 9-day stretch, shares of Pfizer Inc. (NYSE: PFE) were observed to exhibit a Historic Volatility measurement of 8.75%. That figure, when expanded to ...
Corticosteroid Nasal Spray Market Research Report By 2025 With Pfizer, Inc., Bayer Consumer Care, Aegis Therapeutics LLC, Alza Corporation, AptarGroup, Inc. Healthcare News
The Research Insights has published an innovative data, titled as Corticosteroid Nasal Spray market. To discover the desired statistics for prediction of the ...
?Global Oral Antiplatelets Market 2019 - Bayer AG, Pfizer Inc, Merck, Sanofi, Abbott Laboratories Thefeedgraph
Home · ?Global Oral Antiplatelets Market 2019 ? Bayer AG, Pfizer Inc, Merck, Sanofi, Abbott Laboratories · May 25, 2019 index market research General News ...
Big Day for Q1 Earnings: MCD, PFE, GE & More Zacks.com
After today's close, we will hear from Apple Inc. (AAPL). This morning, here are a few of the big names reporting.
A Deep Dive into the Insider Trading: Pfizer Inc. (PFE), Occidental Petroleum Corporation (OXY) Financial Mercury
Looking at top Wall Street opinions, Pfizer Inc. (NYSE: PFE) has recently made its way into the research list of Citigroup ? signaling that their analyst's rating ...
Pfizer Com (PFE) Shares Declined While First American Bank Upped Its Position; Cohen & Steers Holding in Equity Residential (EQR) Boosted as Share Price Rose The NBO News
First American Bank increased its stake in Pfizer Inc Com (PFE) by 5.43% based on its latest 2018Q4 regulatory filing with the SEC. First American Bank bought ...
Cim Maintains Holding in Mccormick & Co (MKC); Pfizer (PFE) Holder Advisors Preferred Lowered Stake as Shares Declined The NBO News
Cim Llc increased its stake in Mccormick & Co Inc (MKC) by 95.96% based on its latest 2018Q4 regulatory filing with the SEC. Cim Llc bought 3397 shares as ...
Donaldson Capital Management Increased Pfizer Com (PFE) Position by $961,093; Altrinsic Global Advisors Stake In Vodafone Group Plc New (VOD) Was Lifted The NBO News
Donaldson Capital Management Llc increased its stake in Pfizer Inc Com (PFE) by 3.02% based on its latest 2018Q4 regulatory filing with the SEC. Donaldson ...
Can Pfizer get Xeljanz, Xtandi pumping while it waits for pipeline help? FiercePharma
Pfizer's Xtandi market share in nonmetastatic, castration-resistant prostate cancer is double that of competitor Erleada's, company executives said Tuesday.
Pfizer (PFE) Holder Asset Management Group Has Boosted Its Position by $313,298 as Stock Value Declined; Holder Channing Capital Management Has Increased Aramark (ARMK) Stake The NBO News
Asset Management Group Inc increased its stake in Pfizer Inc (PFE) by 19.67% based on its latest 2018Q4 regulatory filing with the SEC. Asset Management ...
Pfizer (PFE) Shareholder Brandes Investment Partners LP Cut Its Position; As USG (USG) Market Value Rose, Barnett & Company Decreased by $508,620 Its Stake The NBO News
Brandes Investment Partners Lp decreased its stake in Pfizer Inc (PFE) by 8.9% based on its latest 2018Q4 regulatory filing with the SEC. Brandes Investment ...
As Sina (SINA) Stock Price Rose, Shareholder Tt International Trimmed Holding by $12.59 Million; Stuyvesant Capital Management Decreased Pfizer (PFE) Position by $2.58 Million The EN Herald
Tt International decreased its stake in Sina Corp (SINA) by 26.62% based on its latest 2018Q4 regulatory filing with the SEC. Tt International sold 237530 ...
Pfizer, Merck KGaA's latest Bavencio nod sets up 3-way kidney cancer battle FiercePharma
The FDA approved Pfizer and Merck KGaA's Bavencio in combination with Inlyta for the first-line treatment of patients with advanced kidney cancer. (Pfizer).